Cargando…
Assessment of the Frail Patient With End‐Stage Liver Disease: A Practical Overview of Sarcopenia, Physical Function, and Disability
Frailty has emerged as a powerful predictor of clinical outcomes (e.g., decompensation, hospitalization, mortality) in patients with end‐stage liver disease (ESLD). It is therefore of paramount importance that all patients with ESLD undergo an assessment of frailty, to support life and death decisio...
Autores principales: | Williams, Felicity R, Milliken, Don, Lai, Jennifer C, Armstrong, Matthew J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8183168/ https://www.ncbi.nlm.nih.gov/pubmed/34141980 http://dx.doi.org/10.1002/hep4.1688 |
Ejemplares similares
-
Sarcopenia in Children With End‐Stage Liver Disease on the Transplant Waiting List
por: Woolfson, Jessica P., et al.
Publicado: (2021) -
Use of the FRAIL Questionnaire in Patients With End-Stage Kidney Disease
por: Jegatheswaran, Januvi, et al.
Publicado: (2020) -
Lower insulin level is associated with sarcopenia in community-dwelling frail and non-frail older adults
por: Lu, Yanxia, et al.
Publicado: (2022) -
Beta-blockers and physical frailty in patients with end-stage liver disease
por: Kuo, Selena Z, et al.
Publicado: (2018) -
Dysregulated homeostatic pathways in sarcopenia among frail older adults
por: Ng, Tze Pin, et al.
Publicado: (2018)